Workshop | Virtual
Event Title
Public Workshop on COVID-19 Lessons Learned: Clinical Evaluation of Therapeutics
September 28, 2021
- Date:
- September 28, 2021
The purpose of this public workshop is to share lessons learned from the Federal COVID-19 Response or Countermeasures Acceleration Groups (formerly known as Operation Warp Speed) to bring relevant therapeutics to use in a public health emergency. To learn more about the public workshop, including the agenda, please visit: https://reaganudall.org/news-and-events/events/public-workshop-covid-19-lessons-learned-clinical-evaluation-therapeutics.
Workshop Summary
A summary of the workshop is available on the Reagan-Udall Foundation meeting webpage.
PUBLIC COMMENT
Individuals and organizations may submit comments on this public workshop by December 28, 2021 through the public docket. Please search “COVID-19 lessons learned” on Regulations.gov. For more information about the comment submission process, please visit the Regulations.gov Frequently Asked Questions page.
CONTACT
Kevin Bugin, PhD
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Email: Kevin.Bugin@fda.hhs.gov
Meghana Chalasani, MHA
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Email: Meghana.Chalasani@fda.hhs.gov